help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, K. W.
Right arrow Articles by Leung, P. C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, K. W.
Right arrow Articles by Leung, P. C. K.
Endocrinology Vol. 141, No. 10 3611-3622
Copyright © 2000 by The Endocrine Society

ARTICLES

Transcriptional Down-Regulation of Human Gonadotropin-Releasing Hormone (GnRH) Receptor Gene by GnRH: Role of Protein Kinase C and Activating Protein 11

Kwai Wa Cheng, Elly S. W. Ngan, Sung Keun Kang2, Billy K. C. Chow and Peter C. K. Leung3

Department of Obstetrics and Gynecology, University of British Columbia (K.W.C., S.K.K., P.C.K.L.), Vancouver, Canada V6H 3V5; and Department of Zoology, University of Hong Kong (E.S.W.N., B.K.C.C.), Hong Kong, China

Address all correspondence and requests for reprints to: Peter C. K. Leung, Ph.D., Department of Obstetrics and Gynecology, University of British Columbia, 2H30–4490 Oak Street, British Columbia Women’s Hospital, Vancouver, British Columbia, Canada V6H 3V5. E-mail: peleung{at}interchange.ubc.ca

Clinical applications of GnRH agonists (GnRHa) are based primarily on the decrease in gonadotropin release after down-regulation of the GnRH receptor (GnRHR) by continuous GnRHa administration. However, the molecular mechanisms underlying the transcriptional regulation of the human GnRHR gene after prolonged GnRH treatment remain poorly understood. In the present study GnRHa-mediated regulation of human GnRHR gene transcription was studied by transiently transfecting the mouse gonadotrope-derived ({alpha}T3–1) cells with a 2297-bp human GnRHR promoter-luciferase construct (p2300-LucF). A dose- and time-dependent decrease in human GnRHR promoter activity was observed after GnRHa treatment. An average 71% decrease in promoter activity was observed after 24-h treatment with 0.1 µM GnRHa, which was blocked by cotreatment of the GnRH antagonist, antide. This effect was mimicked by phorbol 12-myristate 13-acetate (TPA) administration. In addition, the GnRHa- and TPA-mediated decrease in the human GnRHR promoter activity was reversed by a specific protein kinase C (PKC) inhibitor, GF109203X, or depletion of PKC by TPA pretreatment. These findings indicate that the activation of the PKC pathway is important in regulating the human GnRHR gene expression.

By progressive 5'-deletion studies, we have identified a 248-bp DNA fragment (-1018 to -771, relative to the translation start site) at the 5'-flanking region of the human GnRHR gene that is responsible for the GnRHa-mediated down-regulation of human GnRHR promoter activity. Analysis of this sequence reveals the existence of two putative activating protein-1 (AP-1) sites with 87% homology to the consensus sequence (5'-TGAG/CTC/AA-3'), located at -1000 to -994 (5'-TTAGACA-3', in complementary orientation) and -943 to -937 (5'-TGAATAA-3'). Using competitive gel mobility shift assays, AP-1 binding was observed within this 248-bp region. Site-directed mutation of the putative AP-1-binding site located at -1000 to -994 abolished the GnRHa-induced inhibition. Further competitive GMSA and supershift experiments confirmed the identity of AP-1 binding in this region. By the use of Western blot analysis, a significant increase in c-Jun (100%; P < 0.05) and c-Fos (50%; P < 0.05) protein levels was observed after GnRHa treatment in {alpha}T3–1 cells. In addition, our data suggested that a change in AP-1 composition, particularly c-Fos, was important in mediating GnRHa-induced inhibition of human GnRHR gene expression.

We conclude that activation of the PKC pathway by GnRH is important in controlling human GnRHR gene expression. In addition, the putative AP-1-binding site located at -1000 to -994 of the human GnRHR 5'-flanking region has been functionally identified to be involved in mediating this down-regulatory effect.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
M. Liao, Y. Zhang, and M. L. Dufau
Protein Kinase C{alpha}-Induced Derepression of the Human Luteinizing Hormone Receptor Gene Transcription through ERK-Mediated Release of HDAC1/Sin3A Repressor Complex from Sp1 Sites
Mol. Endocrinol., June 1, 2008; 22(6): 1449 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Klausen, D. L. Severson, J. P. Chang, and H. R. Habibi
Role of PKC in the regulation of gonadotropin subunit mRNA levels: interaction with two native forms of gonadotropin-releasing hormone
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1634 - R1643.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C.-M. Yeung, B.-S. An, C. K. Cheng, B. K.C. Chow, and P. C.K. Leung
Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells
Mol. Hum. Reprod., November 1, 2005; 11(11): 837 - 842.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Abdelmegeed, N. J. Carruthers, K. J. Woodcroft, S. K. Kim, and R. F. Novak
Acetoacetate Induces CYP2E1 Protein and Suppresses CYP2E1 mRNA in Primary Cultured Rat Hepatocytes
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 203 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. K. Cheng and P. C. K. Leung
Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans
Endocr. Rev., April 1, 2005; 26(2): 283 - 306.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Liu, D. A. Austin, and N. J. G. Webster
Gonadotropin-Releasing Hormone-Desensitized L{beta}T2 Gonadotrope Cells Are Refractory to Acute Protein Kinase C, Cyclic AMP, and Calcium-Dependent Signaling
Endocrinology, October 1, 2003; 144(10): 4354 - 4365.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. L. C. Hoo, E. S. W. Ngan, P. C. K. Leung, and B. K. C. Chow
Two Inr Elements Are Important for Mediating the Activity of the Proximal Promoter of the Human Gonadotropin-Releasing Hormone Receptor Gene
Endocrinology, February 1, 2003; 144(2): 518 - 527.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. V. Vasilyev, M. A. Lawson, D. Dipaolo, N. J. G. Webster, and P. L. Mellon
Different Signaling Pathways Control Acute Induction versus Long-Term Repression of LH{beta} Transcription by GnRH
Endocrinology, September 1, 2002; 143(9): 3414 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Herbst, B. D. Anawalt, J. K. Amory, and W. J. Bremner
Acyline: The First Study in Humans of a Potent, New Gonadotropin-Releasing Hormone Antagonist
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3215 - 3220.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. K. Cheng, C. M. Yeung, B. K. C. Chow, and P. C. K. Leung
Characterization of a New Upstream GnRH Receptor Promoter in Human Ovarian Granulosa-Luteal Cells
Mol. Endocrinol., July 1, 2002; 16(7): 1552 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Junoy, H. Maccario, J.-L. Mas, A. Enjalbert, and S. V. Drouva
Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC ({alpha}, {epsilon}, {zeta}) in {alpha}T3-1 and L{beta}T2 Gonadotrope Cell Lines
Endocrinology, April 1, 2002; 143(4): 1386 - 1403.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Wurmbach, T. Yuen, B. J. Ebersole, and S. C. Sealfon
Gonadotropin-releasing Hormone Receptor-coupled Gene Network Organization
J. Biol. Chem., December 7, 2001; 276(50): 47195 - 47201.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. W. Cheng, C.-K. Cheng, and P. C. K. Leung
Differential Role of PR-A and -B Isoforms in Transcription Regulation of Human GnRH Receptor Gene
Mol. Endocrinol., December 1, 2001; 15(12): 2078 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. W. Cheng, B. K. C. Chow, and P. C. K. Leung
Functional Mapping of a Placenta-Specific Upstream Promoter for Human Gonadotropin-Releasing Hormone Receptor Gene
Endocrinology, April 1, 2001; 142(4): 1506 - 1516.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. Pincas, J.-N. Laverriere, and R. Counis
Pituitary Adenylate Cyclase-activating Polypeptide and Cyclic Adenosine 3',5'-Monophosphate Stimulate the Promoter Activity of the Rat Gonadotropin-releasing Hormone Receptor Gene via a Bipartite Response Element in Gonadotrope-derived Cells
J. Biol. Chem., June 22, 2001; 276(26): 23562 - 23571.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society